Clinical Trials Browser

Phase 1 × Leukemia-Lymphoma, Adult T-Cell × Lenalidomide × Clear all

NCT01169298 2019-11-08

A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients With Advanced Adult T-cell Leukemia-lymphoma and Peripheral T-cell Lymphomaperipheral T-cell Lymphoma

Phase 1 Completed

LymphoidOther hematologic neoplasm

Leukemia-Lymphoma, Adult T-Cell, Lymphoma, T-Cell, Peripheral